Brand family
Akynzeo
Netupitant and Palonosetron and Fosnetupitant and Palonosetron · Helsinn Therapeutics
United States
- Presentations
- 2
- Markets
- 1
Akynzeo is a brand of Netupitant and Palonosetron and Fosnetupitant and Palonosetron marketed by Helsinn Therapeutics, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Netupitant and Palonosetron, Fosnetupitant and Palonosetron
- Brand owner
- Helsinn Therapeutics
- Registered in
- United States
- Strengths and forms
- 300 mg/0.5 mg capsule, 260 mg/0.28 mg per 20 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Akynzeo 300 mg/0.5 mg capsuleOral Cold chain | Helsinn Therapeutics | US FDA | Available on request |
| Akynzeo 260 mg/0.28 mg per 20 mL injectionIntravenous Cold chain | Helsinn Therapeutics | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Akynzeo
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.